A Pilot Trial of Vorinostat Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Trial Profile

A Pilot Trial of Vorinostat Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2017

At a glance

  • Drugs Vorinostat (Primary) ; Ciclosporin; Ciclosporin; Methotrexate; Tacrolimus; Tacrolimus
  • Indications Graft-versus-host disease
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jan 2016 Status changed from recruiting to completed as reported by ClinicaTrials.gov record.
    • 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov. (NCT01789255)
    • 20 May 2013 Planned initiation date changed from 1 Feb 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov. (NCT01789255)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top